Figure 6.
Figure 6. CD4+ CD25+ cells prevent expansion of hapten-specific CD8+ T cells. Ii°/° mice were either left untreated or were transferred intravenously on day –8 with either naive total CD4+ T cells (10 × 106), CD4+CD25– T cells (9 × 106), or CD4+CD25+ T cells (1 × 106), fed with DNFB on day –7 and skin sensitized on day 0 with DNFB. Purified CD8+ T cells (2 × 105) from spleen and lymph nodes, harvested on day 5 after sensitization, were restimulated in vitro for 3 days with syngeneic mitomycin C–treated spleen cells (5 × 105) either untreated or pulsed with DNBS. T-cell proliferation was determined by [3H]thymidine uptake during the last 8 hours. Results are expressed as Δcpm values (ie, cpm from hapten-derivatized spleen cells – cpm from untreated spleen cells) ± SD of triplicate wells.

CD4+ CD25+ cells prevent expansion of hapten-specific CD8+ T cells. Ii°/° mice were either left untreated or were transferred intravenously on day –8 with either naive total CD4+ T cells (10 × 106), CD4+CD25 T cells (9 × 106), or CD4+CD25+ T cells (1 × 106), fed with DNFB on day –7 and skin sensitized on day 0 with DNFB. Purified CD8+ T cells (2 × 105) from spleen and lymph nodes, harvested on day 5 after sensitization, were restimulated in vitro for 3 days with syngeneic mitomycin C–treated spleen cells (5 × 105) either untreated or pulsed with DNBS. T-cell proliferation was determined by [3H]thymidine uptake during the last 8 hours. Results are expressed as Δcpm values (ie, cpm from hapten-derivatized spleen cells – cpm from untreated spleen cells) ± SD of triplicate wells.

Close Modal

or Create an Account

Close Modal
Close Modal